Last reviewed · How we verify
NCT05575752
Acute Health Effects of High Temperature Exposure
NA trial testing high temperature (32℃) group in Cardiovascular System in 30 participants. Participants enrolled and being followed up; not accepting new ones.
19 November 2022
Quick facts
| Lead sponsor | Fudan University |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 23 October 2022 |
| Primary completion | 19 November 2022 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- high temperature (32℃) group
- moderate temperature (22℃) group
Conditions studied
- Cardiovascular System — all drugs for Cardiovascular System →
- Respiratory System — all drugs for Respiratory System →
- Cognitive Function — all drugs for Cognitive Function →
Sponsor
Fudan University
Who can join
Adults 18 to 30, any sex, with Cardiovascular System or Respiratory System. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized controlled human exposure crossover study. Investigators aims to assess the acute effects of high temperature exposure and the underlying mechanisms.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Heat Exposure Changes Lung Function, Biomarkers of Airway Injury, and Airway Microbiota: A Randomized, Crossover Trial.
Zhu Y, Jiang Y, Du X, Zhu X, et al · · 2025 · cited 2× · PMID 41306309 · DOI 10.1021/envhealth.5c00032
Verify or expand the search:
- PubMed search for NCT05575752
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular System
Currently open trials in the same condition.
- NCT07501923 — The Effects of Daytime, Nighttime, and Combined Heat Exposure on Human Health · NA · recruiting
- NCT06652425 — Acute Effects of Cold Exposure on Cardiovascular System · NA · recruiting
- NCT04153539 — Acute Health Effects of Traffic-Related Air Pollution Exposure · NA · active not recruiting
Other Fudan University trials
Trials by the same sponsor.
- NCT06196671 — Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer · Phase 2 · not yet recruiting
- NCT07423611 — ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer · Phase 2 · not yet recruiting
- NCT07410559 — Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Bre · Phase 2 · not yet recruiting
- NCT07490119 — Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer · Phase 2 · not yet recruiting
- NCT07497919 — A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05575752 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fudan University
- Last refreshed: 26 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05575752.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing